Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by retiredcopon Apr 15, 2021 12:40pm
174 Views
Post# 33003548

RE:RE:RE:PMN wishes from three weeks ago..

RE:RE:RE:PMN wishes from three weeks ago.. You may have overlooked something.. you mentioned that there were millions of shares bought... how about m illions of shares SOLD.... this is where the short term porfit traders come into play. A few weeks ago they spotted a stock that was climbing and tons of volume. they bought with aniticpation that the stock could be making a breakout ... the stock moved from the low teens to the low 20's. After a week the stock levelled out in volumme, the share price became stagnent in the low 20's. many of them figured out that the expected news looked like it was going to be delayed . So we see a sudden surge of selling /buying in ther low 20's and when those asks and bids wore out, the objective is to drive the shares back down .. and then you start to rebuy in anticipatiom of the next surge in the stock price. These guys are doing this everyday, with numerous stocks, not just PMN. You can get upset with them but how many of us are buying and selling and making a few thousand dollars a day. I would like to do this but you need to be wathcing your stock ticker from opening to closing and be ready to move at a moments notice. The other thing is that this daily trading ( in CRA's view) becomes income and is taxed on the full amount of gain and not 50%  as we expect with capital;gain rules. I think you can canvas a few of the people on this  message board and they will be very honest and tell you thats what they do.  They take the expression  " buy low -sell high"  to a different  level.   
<< Previous
Bullboard Posts
Next >>